WealthTrak Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

WealthTrak Capital Management’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1	Closed	-$132	–	1094
2025 Q1	$132	Buy	+1	New	+$125	﹤0.01%	911

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

WealthTrak Capital Management's ITCI Position: Q2 2025 in Review

WealthTrak Capital Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 1 share — an estimated $132 sold.

WealthTrak Capital Management first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $132 in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

WealthTrak Capital Management reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
WealthTrak Capital Management sold 1 Intra-Cellular Therapies Inc. share in Q2 2025, an estimated $132.
WealthTrak Capital Management first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
WealthTrak Capital Management's Intra-Cellular Therapies Inc. position peaked at $132 in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on WealthTrak Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.